Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug:60:8-14.
doi: 10.1016/j.annepidem.2021.04.005. Epub 2021 Apr 22.

Incidence of COVID-19 recurrence among large cohort of healthcare employees

Affiliations

Incidence of COVID-19 recurrence among large cohort of healthcare employees

Fitzpatrick Veronica et al. Ann Epidemiol. 2021 Aug.

Abstract

Purpose: To quantify COVID-19 recurrence among clinical and nonclinical healthcare employees with SARS-CoV-2 IgG antibodies or prior COVID-19 infection.

Methods: This prospective, cohort study collected and resulted SARS-CoV-2 IgG serum samples as positive or negative from June 8 to July 10, 2020 from a convenience sample of 16,233 adult participants employed by a large Midwestern healthcare system. Documented positive polymerase chain reaction test results representing COVID-19 infections were recorded up to four months prior to and post-IgG testing.

Results: Nine hundred and thirteen (6.12%) participants, including 45 (4.93%) IgG positive participants, experienced COVID-19 infections after study initiation, representing a 51% increased risk of COVID-19 infection among IgG positive participants (IRR = 1.51). Regressions adjusted for documented disparities showed no difference in COVID-19 infection by IgG status (OR=1.19; P = .3117) but significantly greater odds in COVID-19 recurrence among participants with a prior documented COVID-19 infection (OR=1.93; P < .0001).

Conclusions: SARS-CoV-2 IgG antibodies and prior COVID-19 infection do not appear to offer meaningful protection against COVID-19 recurrence in healthcare workers. Recurrence would impact decisions regarding ongoing healthcare resource utilization. This study can inform considerations for vaccine administration to vulnerable groups.

Keywords: Covid-19; Epidemiology; Infectious diseases.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Flow diagram of prospective cohort study.

References

    1. Edridge A.D.W., Kaczorowska J., Hoste A.C.R., Bakker M., Klein M., Jebbink M.F., et al. 2020. Coronavirus protective immunity is short-lasting. medRxiv. - DOI - PubMed
    1. Elsayed S.M., Reddy M.K., Murthy P.M., et al. The possibility and cause of relapse after previously recovering from COVID-19: a systematic review. Cureus. 2020;12:e10264. doi: 10.7759/cureus.10264. - DOI - PMC - PubMed
    1. Wang B., Wang L., Kong X., et al. Long-term existence of SARS-CoV-2 with antibody response in COVID-19 patients. J Med Virol. 2020;92(9):1684–1689. - PMC - PubMed
    1. Robbiani D.F., Gaebler C., Muecksch F., Lorenzi J.C.C., Wang Z., Cho A., et al. Convergent antibody responses to SARS-CoV-2 infection in convalescent individuals. Nature. 2020;584:437–442. doi: 10.1038/s41586-020-2456-9. - DOI - PMC - PubMed
    1. Kirkcaldy R.D., King B.A., Brooks J.T. COVID-19 and post-infection immunity: limited evidence, many remaining questions. JAMA. 2020;323:2245–2246. doi: 10.1001/jama.2020.7869. - DOI - PMC - PubMed

Substances